⏰ Last chance! Join Premium for $20/month before it increases to $49/month.

Monopar Therapeutics Inc. Common Stock

$96.68
+0.47 (+0.49%)

Volume:

35.047K ($3.39M)

Market Capitalization:

$648.93M

Live Price

Live Volume

Chart Volume 0
Volume 0
5 sec

Monopar Therapeutics Market Segments

Regular Trading Hours

-1.24(-1.27%)
Open$97.92
Close$96.68
Low$96.14
Low Change-1.78 (-1.82%)
High$98.19
High Change+0.27 (+0.28%)
Range$2.05
Volume30.831K
Dollar Volume$2.98M

Premarket

+0.95(+0.98%)
Open$96.55
Close$97.50
Low$96.55
Low Change0.00 (0.00%)
High$97.50
High Change+0.95 (+0.98%)
Range$0.95
Volume4.216K
Dollar Volume$411.06K

Overnight

*No Trades in Segment

After Hours Yesterday

+0.00(+0.00%)
Open$96.47
Close$96.47
Low$96.47
Low Change0.00 (0.00%)
High$96.47
High Change+0.00 (+0.00%)
Range$0.00
Volume255.834K
Dollar Volume$24.68M

Regular Trading Hours Yesterday

-6.23(-6.08%)
Open$102.44
Close$96.21
Low$95.96
Low Change-6.49 (-6.33%)
High$102.45
High Change+0.01 (+0.01%)
Range$6.50
Volume106.452K
Dollar Volume$10.24M

Premarket Yesterday

*No Trades in Segment

Monopar Therapeutics News

There is no current news for this stock at the moment.

Monopar Therapeutics Top Trades

Monopar Therapeutics's top trade so far today returned +1.70%, while the top short trade returned -1.82%.

Monopar Therapeutics Moving Averages

5 Day Moving Average (SMA5)$102.63
10 Day Moving Average (SMA10)$107.85
20 Day Moving Average (SMA20)$110.69
50 Day Moving Average (SMA50)$111.55
100 Day Moving Average (SMA100)$90.07
200 Day Moving Average (SMA200)$76.06

Monopar Therapeutics Statistics

Average Volume (30 Days)175.81K
P/E Ratio (Current)-38.61
EPS (Current)-$2.66
Dividend Yield0.00%
Free Cash Flow-$12.18M
Cash Ratio13.14
Current Ratio33.56
Quick Ratio33.56
Debt to Equity0.00
Enterprise Value$636.58M
EV to EBITDA-28.78
EV to Sales
Price to Book5.27
Price to Cash Flow
Price to Free Cash Flow
Price to Sales
Return on Assets-0.13%
Return on Equity-0.14%

Monopar Therapeutics Stock Splits

There has been 1 stock split for Monopar Therapeutics (MNPR). The reverse stock split occured on August 13, 2024 and reduced the outstanding shares at a ratio of 5:1.

DateTypeRatio
Aug 13, 2024Reverse5:1

Monopar Therapeutics Dividends

There have been no dividends for Monopar Therapeutics (MNPR).